<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(2)</volume><submitter>Ono M</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>With improvements in early survival after the stage I palliation (S1P) Norwood procedure for hypoplastic left heart syndrome (HLHS) and its variants, inter-stage death accounts for an increasing proportion of mortality. Our aim was to identify the risk factors for inter-stage mortality.&lt;h4>Methods&lt;/h4>The records of 322 neonates with HLHS or a variant who underwent the Norwood procedure at our centre between 2001 and 2019 were retrospectively analysed.&lt;h4>Results&lt;/h4>The diagnoses included 271 neonates with HLHS (84%) and 51 with variants (16%). Aortic atresia was observed in 138 (43%) patients, mitral atresia in 91 (28%), extracardiac anomalies in 42 (13%) and genetic disorder in 14 (4%). The median age and weight of the patients at the S1P Norwood procedure were 9 (int</pubmed_abstract><journal>Interactive cardiovascular and thoracic surgery</journal><pagination>218-226</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8691571</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Preoperative risk factors influencing inter-stage mortality after the Norwood procedure.</pubmed_title><pmcid>PMC8691571</pmcid><pubmed_authors>Ono M</pubmed_authors><pubmed_authors>Horer J</pubmed_authors><pubmed_authors>Wallner M</pubmed_authors><pubmed_authors>Ewert P</pubmed_authors><pubmed_authors>Cleuziou J</pubmed_authors><pubmed_authors>Burri M</pubmed_authors><pubmed_authors>Hager A</pubmed_authors><pubmed_authors>Lemmer J</pubmed_authors><pubmed_authors>Strbad M</pubmed_authors><pubmed_authors>Kido T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preoperative risk factors influencing inter-stage mortality after the Norwood procedure.</name><description>&lt;h4>Objectives&lt;/h4>With improvements in early survival after the stage I palliation (S1P) Norwood procedure for hypoplastic left heart syndrome (HLHS) and its variants, inter-stage death accounts for an increasing proportion of mortality. Our aim was to identify the risk factors for inter-stage mortality.&lt;h4>Methods&lt;/h4>The records of 322 neonates with HLHS or a variant who underwent the Norwood procedure at our centre between 2001 and 2019 were retrospectively analysed.&lt;h4>Results&lt;/h4>The diagnoses included 271 neonates with HLHS (84%) and 51 with variants (16%). Aortic atresia was observed in 138 (43%) patients, mitral atresia in 91 (28%), extracardiac anomalies in 42 (13%) and genetic disorder in 14 (4%). The median age and weight of the patients at the S1P Norwood procedure were 9 (int</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2026-07-09T12:06:07.886Z</modification><creation>2025-04-05T14:43:19.781Z</creation></dates><accession>S-EPMC8691571</accession><cross_references><pubmed>33948647</pubmed><doi>10.1093/icvts/ivab073</doi></cross_references></HashMap>